-
1 Comment
Braster S.A. is currently in a long term uptrend where the price is trading 9.0% above its 200 day moving average.
Braster S.A.'s total revenue sank by 66.3% to $21K since the same quarter in the previous year.
Its net income has increased by 62.3% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 69.2% to $-3M since the same quarter in the previous year.
Based on the above factors, Braster S.A. gets an overall score of 3/5.
| Exchange | WAR |
|---|---|
| CurrencyCode | PLN |
| Industry | Medical Devices |
| ISIN | PLBRSTR00014 |
| Sector | Healthcare |
| PE Ratio | None |
|---|---|
| Market Cap | 17M |
| Beta | 0.48 |
| Target Price | 29 |
| Dividend Yield | None |
Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination through Braster telemedical centers. The company was founded in 2008 and is headquartered in Ozarów Mazowiecki, Poland.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BRA.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
